GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (FRA:1RT) » Definitions » Stock Based Compensation

Nuformix (FRA:1RT) Stock Based Compensation : €0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Nuformix Stock Based Compensation?

Nuformix's Stock Based Compensation for the six months ended in Mar. 2025 was €0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 was €0.00 Mil.


Nuformix Stock Based Compensation Historical Data

The historical data trend for Nuformix's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Stock Based Compensation Chart

Nuformix Annual Data
Trend Dec15 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Sep24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only 0.12 0.22 0.03 0.03 0.01

Nuformix Semi-Annual Data
Dec15 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24 Sep24 Mar25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 - - -

Nuformix Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.


Nuformix Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Nuformix's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix Headlines

No Headlines